Skip to main content
ImmuneCited

[Pelargonium sidoides-extract (EPs 7630): registration confirms efficacy and safety].

Andreas Conrad, Herbert Kolodziej, Volker Schulz
Review Wiener medizinische Wochenschrift (1946) 2007 23 atıf
PubMed DOI
<\/script>\n
`; }, get iframeSnippet() { const domain = 'immunecited.com'; const params = 'pmid\u003D17704982'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

Study Design

Çalışma Türü
Review
Popülasyon
None
Müdahale
[Pelargonium sidoides-extract (EPs 7630): registration confirms efficacy and safety]. None
Karşılaştırıcı
None
Birincil Sonuç
[Pelargonium sidoides-extract (EPs 7630): registration confirms efficacy and saf
Etki Yönü
Mixed
Yanlılık Riski
Unclear

Abstract

For centuries the roots of Pelargonium sidoides DC have been used in South African ethno-medicine for the treatment of respiratory diseases. In Germany, a medicinal product containing a special extract of this substance is among the group of self-medication products most widely bought at chemist's shops. In December 2005, the Federal Institute for Drugs and Medical Devices (BfArM, Bonn) approved a new license for its use as a drug. The following review focuses on the current pharmacological, toxicological and clinical data covering the efficacy and innocuousness of this drug when administered for the treatment of acute bronchitis.

Kısaca

The following review focuses on the current pharmacological, toxicological and clinical data covering the efficacy and innocuousness of this drug when administered for the treatment of acute bronchitis.

Used In Evidence Reviews

Similar Papers